PUBLISHER: The Business Research Company | PRODUCT CODE: 1945522
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945522
A medical centrifuge is a machine designed to use centrifugal force for the separation of different densities of items, removal of moisture, or simulation of gravity forces. These devices find application in various laboratories to separate fluids, gases, or liquids based on their density.
The primary types of medical centrifuges include bench-top, floor-standing, tabletop, and portable models. A benchtop centrifuge is a compact, countertop-sized centrifuge designed for laboratory use, primarily employed to apply centrifugal force and separate elements in a liquid or solid mixture. The capacity of these centrifuges includes microcentrifuge, medium capacity centrifuge, and large capacity centrifuge, maintained at both refrigerated and non-refrigerated temperatures. They are utilized by hospitals, clinics, ambulatory surgical centers, and other medical facilities.
Tariffs are impacting the medical centrifuge market by increasing costs of imported motors, rotors, electronic controllers, and precision mechanical components. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported centrifuge systems, while Asia-Pacific faces cost pressures on export manufacturing. These tariffs are raising equipment procurement costs and delaying replacements. However, they are also encouraging local manufacturing, regional assembly, and development of cost-optimized centrifuge models.
The medical centrifuge market research report is one of a series of new reports from The Business Research Company that provides medical centrifuge market statistics, including medical centrifuge industry global market size, regional shares, competitors with a medical centrifuge market share, detailed medical centrifuge market segments, market trends and opportunities, and any further data you may need to thrive in the medical centrifuge industry. This medical centrifuge market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical centrifuge market size has grown strongly in recent years. It will grow from $2.13 billion in 2025 to $2.29 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to expansion of diagnostic laboratory infrastructure, rising use of blood component separation, growth in clinical testing volumes, increasing research laboratory setups, wider adoption of centrifugation in medical diagnostics.
The medical centrifuge market size is expected to see strong growth in the next few years. It will grow to $3.08 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing equipment, rising investments in molecular diagnostics, expansion of decentralized laboratories, growing focus on automation in sample processing, increasing adoption of energy-efficient laboratory devices. Major trends in the forecast period include increasing adoption of compact and portable centrifuges, rising demand for high-speed separation systems, growing integration of digital control interfaces, expansion of refrigerated centrifuge usage, enhanced focus on laboratory workflow efficiency.
The rising incidence of chronic diseases is projected to support the expansion of the medical centrifuge market in the coming years. Chronic diseases are long-term health conditions, including cardiovascular disorders, diabetes, cancer, and respiratory illnesses, that generally worsen over time and require ongoing medical care. The growing burden of these conditions is largely attributed to unhealthy lifestyle patterns, as sedentary behavior and poor dietary habits increasingly contribute to the development of persistent health issues. As a result, demand within the medical centrifuge industry is increasing, as the rapid growth in chronic disease cases encourages healthcare providers and laboratories to adopt advanced sample preparation and diagnostic support solutions that enhance testing efficiency and aid clinical decision-making. For example, in April 2025, according to the U.S. Centers for Disease Control and Prevention, a United States-based national public health agency, approximately 76.4% of U.S. adults, representing around 194 million people, were living with at least one chronic condition in 2023, with prevalence rates of 59.5% among young adults, 78.4% among middle-aged adults, and 93.0% among older adults. Consequently, the growing prevalence of chronic diseases is driving demand for medical centrifuges.
Major companies in the medical centrifuge market are launching innovative products to maintain their competitive edge. For example, in August 2023, Boekel Scientific, a US-based company recognized for designing and manufacturing high-quality laboratory equipment and medical devices, introduced a new range of centrifuges. This range includes four different types: economy, general purpose, STAT, and Blood Bank, catering to various laboratory needs. The centrifuges are available in capacities of 6-place, 12-place, and 24-place, all featuring removable rotors. They incorporate advanced technologies such as LED light indicators and brushless motors, ensuring they uphold the durability and quality for which Boekel Scientific is known. Additionally, these centrifuges are dual voltage and comply with UL/CSA/CE standards, making them suitable for use worldwide.
In July 2023, Beckman Coulter Inc., a United States-based manufacturer of clinical diagnostics and medical laboratory equipment, entered into a partnership with Fujirebio Holdings, Inc. to broaden access to blood-based diagnostic testing for Alzheimer's disease. Through this collaboration, Beckman Coulter and Fujirebio seek to speed up the development and commercialization of highly accurate Alzheimer's diagnostic assays, enhance early detection by optimizing laboratory workflows, and promote wider clinical adoption of blood-based biomarkers for the diagnosis of neurodegenerative disorders. Fujirebio Holdings Inc. is a Japan-based in vitro diagnostics company focused on biomarker-driven testing solutions.
Major companies operating in the medical centrifuge market are Scilogex LLC, Drucker Diagnostics Inc., Sartorius AG, Thermo Fisher Scientific Inc., Andreas Hettich GmbH & Co. KG, Eppendorf AG, HERMLE Labortechnik GmbH, KUBOTA Corporation, Sigma Laborzentrifugen GmbH, Hitachi Koki Co. Ltd., Labnet International Inc., MSE UK Ltd., REMI GROUP, Centurion Scientific Ltd., LaboGene ApS, MPW MED INSTRUMENTS, Unico Inc., ZIRBUS technology GmbH, NuWind, AccuBioTech Co. Ltd., Danaher Corporation, NuAire Inc., Separation Technology Inc., Labocon
North America was the largest region in the medical centrifuge market in 2025. Asia-Pacific is expected to be the fastest-growing region in the medical centrifuge market report during the forecast period. The regions covered in the medical centrifuge market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical centrifuge market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical centrifuge market consists of sales of high-speed centrifuges, low-speed centrifuges, and ultracentrifuges. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Centrifuge Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical centrifuge market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical centrifuge ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical centrifuge market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.